W Bradford Smith - Net Worth and Insider Trading
W Bradford Smith Net Worth
The estimated net worth of W Bradford Smith is at least $738 dollars as of 2024-09-20. W Bradford Smith is the See Remarks of Homology Medicines Inc and owns about 790 shares of Homology Medicines Inc (FIXX) stock worth over $738. Details can be seen in W Bradford Smith's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that W Bradford Smith has not made any transactions after 2023-01-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of W Bradford Smith
W Bradford Smith Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, W Bradford Smith owns 4 companies in total, including Lyra Therapeutics Inc (LYRA) , Homology Medicines Inc (FIXX) , and Ocular Therapeutix Inc (OCUL) among others .
Click here to see the complete history of W Bradford Smith’s form 4 insider trades.
Insider Ownership Summary of W Bradford Smith
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
LYRA | Lyra Therapeutics Inc | 2020-04-30 | director |
FIXX | Homology Medicines Inc | 2023-01-09 | CFO & Treasurer & Secretary |
OCUL | Ocular Therapeutix Inc | 2016-02-02 | See Remarks |
2005-02-14 | Chief Financial Officer |
W Bradford Smith Latest Holdings Summary
W Bradford Smith currently owns a total of 1 stock. W Bradford Smith owns 790 shares of Homology Medicines Inc (FIXX) as of January 9, 2023, with a value of $738.
Latest Holdings of W Bradford Smith
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
FIXX | Homology Medicines Inc | 2023-01-09 | 790 | 0.93 | 738 |
Holding Weightings of W Bradford Smith
W Bradford Smith Form 4 Trading Tracker
According to the SEC Form 4 filings, W Bradford Smith has made a total of 7 transactions in Homology Medicines Inc (FIXX) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Homology Medicines Inc is the sale of 207 shares on January 9, 2023, which brought W Bradford Smith around $5,183.
Insider Trading History of W Bradford Smith
- 1
W Bradford Smith Trading Performance
W Bradford Smith Ownership Network
W Bradford Smith Owned Company Details
What does Lyra Therapeutics Inc do?
Who are the key executives at Lyra Therapeutics Inc?
W Bradford Smith is the director of Lyra Therapeutics Inc. Other key executives at Lyra Therapeutics Inc include director & Executive Chair Harlan Waksal , 10 percent owner Perceptive Life Sciences Master Fund Ltd , and 10 percent owner Nbvm Gp, Llc .
Lyra Therapeutics Inc (LYRA) Insider Trades Summary
Over the past 18 months, W Bradford Smith made no insider transaction in Lyra Therapeutics Inc (LYRA). Other recent insider transactions involving Lyra Therapeutics Inc (LYRA) include a net purchase of 3,610,832 shares made by Perceptive Life Sciences Master Fund Ltd , a net purchase of 1,805,416 shares made by Edward T Anderson , and a net purchase of 1,805,416 shares made by Nbvm Gp, Llc .
In summary, during the past 3 months, insiders sold 0 shares of Lyra Therapeutics Inc (LYRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lyra Therapeutics Inc (LYRA) were sold and 7,246,664 shares were bought by its insiders, resulting in a net purchase of 7,246,664 shares.
Lyra Therapeutics Inc (LYRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lyra Therapeutics Inc Insider Transactions
W Bradford Smith Mailing Address
Above is the net worth, insider trading, and ownership report for W Bradford Smith. You might contact W Bradford Smith via mailing address: C/o Homology Medicines, Inc., One Patriots Park, Bedford Ma 01730.